Area of research
Oncology · Cancer Research
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Cancer Genomics and Diagnostics, and Melanoma and MAPK Pathways.
Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy
Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Primary Resistance to PD-1 Blockade Mediated by <i>JAK1/2</i> Mutations
PD-1 blockade induces responses by inhibiting adaptive immune resistance